Symptom score before and after intervention (median values of 14 days of registration)
| Placebo group | Treated group | ||||
|---|---|---|---|---|---|
| Patient | Before | After | Patient | Before | After |
| *In the treated group significant difference after 1 year compared with before the intervention (p=0.04). | |||||
| Pulmonary symptoms | |||||
| 1 | 1.50 | 0.21 | 1 | 2.71 | 0.42 |
| 2 | 1.33 | 5.20 | 2 | 0.64 | 3.00 |
| 3 | 1.07 | 3.14 | 3 | 3.30 | 5.85 |
| 4 | 0.92 | 0.00 | 4 | 2.14 | 1.30 |
| 5 | 2.38 | 4.78 | 5 | 0.07 | 0.00 |
| 6 | 6.38 | 0.43 | 6 | 2.00 | 1.64 |
| 7 | 2.00 | 0.28 | 7 | 1.14 | 1.50 |
| 8 | 8.35 | 10.92 | 8 | 8.25 | 7.07 |
| 9 | 0.14 | 0.21 | 9 | 3.14 | 2.78 |
| 10 | 0.21 | 0.21 | 10 | 0.92 | 0.35 |
| 11 | 1.21 | 0.14 | 11 | 0.00 | 1.25 |
| 12 | 4.33 | 3.50 | 12 | 2.42 | 5.28 |
| 13 | 0.75 | 4.14 | 13 | 4.00 | 4.09 |
| 14 | 0.00 | 0.00 | 14 | 2.07 | 1.42 |
| 15 | 0.00 | 0.00 | |||
| 16 | 0.00 | 0.00 | |||
| Median | 1.27 | 0.36 | 2.04 | 1.46 | |
| Range | (00–8.35) | (00–10.92) | (00–8.25) | (00–7.07) | |
| Nasal symptoms | |||||
| 1 | 1.71 | 0.86 | 1 | 4.57 | 2.42 |
| 2 | 2.14 | 4.00 | 2 | 3.21 | 2.16 |
| 3 | 2.50 | 5.70 | 3 | 2.30 | 4.28 |
| 4 | 0.00 | 0.00 | 4 | 2.50 | 0.10 |
| 5 | 5.00 | 2.50 | 5 | 1.42 | 0.57 |
| 6 | 5.23 | 4.71 | 6 | 0.64 | 0.50 |
| 7 | 1.00 | 0.00 | 7 | 6.57 | 5.21 |
| 8 | 7.64 | 10.92 | 8 | 5.00 | 4.07 |
| 9 | 0.35 | 0.71 | 9 | 1.92 | 2.00 |
| 10 | 0.64 | 0.28 | 10 | 3.23 | 0.50 |
| 11 | 0.14 | 0.00 | 11 | 0.00 | 0.00 |
| 12 | 11.16 | 2.00 | 12 | 1.42 | 1.00 |
| 13 | 2.85 | 2.71 | 13 | 0.16 | 1.00 |
| 14 | 0.00 | 0.00 | 14 | 0.75 | 0.42 |
| 15 | 0.00 | 0.00 | |||
| 16 | 0.00 | 0.00 | |||
| Median | 1.93 | 1.43 | 1.67 | 0.79* | |
| Range | (00–11.16) | (00–10.92) | (00–6.57) | (00–5.21) | |